IKPARIMENr CP HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NAIICNAL INSTIIOTES OF HEALTH 
RECOMBINANT ADVISORY COMMITTEE 
MINUTES CF MEETINSl 
JUNE 26, 1982 
Ihe Recombinant ENA Advisory Conmittee (RAC) was convened for its twenty-fifth 
meeting at 9:00 a.m. on June 28, 1982, in Wilson Hall, Building 1, National 
Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20205. 
Mr. Ray Thornton (Chairman), President, Arkansas State Uhiversity, presided. 
In accordance with Public Law 92-463, the meeting was open to the public. 
Committee members present for all or part of the meeting were; 
Abdul Karim Ahmed; David Baltimore; Kenneth Berns; Winston Brill; L. Albert Ealoz; 
David Friedman; Richard Goldstein; Jean Harris; King Holmes; Myron Levine; David 
Martin; James Mason; Gerard McGarrity; Robert McKinney; Robert Mitchell; Elena 
Nightingale; Ramon Pinon; Mark Saginor; John Scandalios; Pieter Wensink; and 
William J. Gartland, Jr., Executive Secretary. 
A Committee roster is attached. (Attachment I) 
The following non-voting members and liaison representatives were present; 
George Duda, Department of Energy; Herman Lewis, National Science Foundation; 
Henry Miller, National Center for Drugs and Biologies, FDA; and Sue Iblin, 
U.S. Department of Agriculture. 
Other National Institutes of Health staff present were; 
Stanley Barban, NIAID; Manuel Barbeito, OD; W. Bonmett Barkley, OD; Becky Connors, 
NIAID; Irving Delappe, NIAID; Susan Gottesman, NCI; John Irwin, OD; Elizabeth 
Milewski, NIAID; Jehn Nutter, NIAID; Robert Schreiber, NIAID; Bernard Talbot, NIAID 
ard Charles Wise, NIAID. 
^Ihe RAC is advisory to the NIH, and its recommendations should not be 
considered as final and accepted. The Office of Recombinant ENA Activities 
should be consulted for NIH policy on specific issues. 
[ 460 ] 
